gdc

Web Exclusives

CAR T-Cell Therapy Emerging for Chronic Lymphocytic Leukemia
Leukemia
Web Exclusives – December 9, 2019
Chimeric antigen receptor (CAR) T-cell therapy could soon expand into chronic lymphocytic leukemia (CLL). Early clinical trials have shown responses in patients with CLL refractory to other therapies. Predicting which patients will respond is key to advancing CAR T-cell therapy into CLL.
Targeted Therapy Dominates CLL Treatment Landscape
Leukemia
Web Exclusives – December 9, 2019
Targeted therapy is at the forefront of chronic lymphocytic leukemia (CLL) treatment. In many cases, targeted agents offer superior outcomes to chemotherapy, with more manageable side effects. Multiple targeted therapy options are available, and some choices depend on certain molecular markers.
Cytogenetic Testing in Chronic Lymphocytic Leukemia
Leukemia
Web Exclusives – December 9, 2019
Cytogenetic testing is used to identify genomic aberrations in patients with chronic lymphocytic leukemia (CLL). It estimates a patient’s outcomes and can predict response to certain therapies, and therefore is recommended for all patients with CLL at diagnosis.
Acalabrutinib Alone or in Combination More Effective than Chemoimmunotherapy in Previously Untreated CLL
Leukemia
Web Exclusives – December 9, 2019
A new study presented at a major medical meeting showed that fewer patients with treatment-naïve chronic lymphocytic leukemia (CLL) who were treated with acalabrutinib alone or in combination with obinutuzumab had disease progression or died compared with a group of patients treated with the combination of obinutuzumab and chemotherapy.
Triplet Regimen with Acalabrutinib Is Highly Active in Untreated Chronic Lymphocytic Leukemia
Leukemia
Web Exclusives – December 9, 2019
A 3-drug regimen of acalabrutinib, venetoclax, and obinutuzumab was highly effective in removing all traces of disease from the bone marrow of patients with chronic lymphocytic leukemia, according to study results presented at the American Society of Hematology annual meeting.
Ovarian Cancer Patient Advocacy Organizations
Ovarian Cancer
Web Exclusives – December 4, 2019
There are a number of excellent organizations providing resources and support to you as a patient with ovarian cancer or a caregiver.
Understanding Pancreatic Cancer
Pancreatic Cancer
Web Exclusives – November 27, 2019
A complex disease, pancreatic cancer has causes that are difficult to identify, and it often goes without symptoms and undiagnosed until the cancer is locally advanced or metastatic.
Pancreatic Cancer Treatment Explained
Pancreatic Cancer
Web Exclusives – November 27, 2019
Depending on the cancer type and stage, along with individual patient factors, pancreatic cancer can be treated with surgery, radiation, chemotherapy, immunotherapy, targeted therapy, supportive care, or a combination of these treatments.
Maintenance Therapy and Quality of Life
Pancreatic Cancer
Web Exclusives – November 27, 2019
Helping patients preserve their quality of life by avoiding major side effects, maintenance therapy is a relatively new but promising form of treatment for pancreatic cancer.
Nutrition for Patients with Pancreatic Cancer
Pancreatic Cancer
Web Exclusives – November 27, 2019
Getting proper nutrition is often difficult for patients with pancreatic cancer, but it is possible with specialized nutritional care and guidance from a registered dietitian.
Page 1 of 10
Results 1 - 10 of 100

Subscribe to CONQUER: the patient voice magazine

Receive timely cancer news & updates, patient stories, and more.

Country